Nicholas Investment Partners’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-157,635	Closed	-$3.55M	–	208
2024 Q4	$3.55M	Sell	157,635 -16,110	-9%	-$362K	0.31%	116
2024 Q3	$4.44M	Buy	173,745 +117,673	+210%	+$3.01M	0.41%	93
2024 Q2	$1.31M	Buy	+56,072	New	+$1.31M	0.14%	158